Delve Insight Market Research Reports

TITLE Actions
Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 2000 Onwards | By Delve Insight

Introduction DelveInsight's, “Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Raynauds Disease . The report includes in...

Vulvovaginal Candidiasis - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Vulvovaginal Candidiasis - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Vulvovaginal Candidiasis epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 20...

Traveler's Diarrhea - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Traveler's Diarrhea - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Traveler's Diarrhea epidemiology and market outlook for the 7MM. Markets Covered - United ...

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 2000 Onwards | By Delve Insight

Introduction DelveInsight's, “Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Rec...

Wet Macular Degeneration - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Wet Macular Degeneration - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Wet Macular Degeneration epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 20...

Typhoid Fever - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Typhoid Fever - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Typhoid Fever epidemiology and market outlook for the 7MM. Markets Covered - United States...

Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 2000 Onwards | By Delve Insight

Introduction DelveInsight's, “Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Malignant Glioma . The report includes in...

Wilson Disease - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Wilson Disease - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Wilson Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. ...

Urea Cycle Disorders - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Urea Cycle Disorders - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Urea Cycle Disorders epidemiology and market outlook for the 7MM. Markets Covered - Unite...

Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 2000 Onwards | By Delve Insight

Introduction DelveInsight's, “Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Relapsed Chron...

Acromegaly and Gigantism Therapeutics - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Acromegaly and Gigantism Therapeutics - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Acromegaly and Gigantism Therapeutics epidemiology, providing the historical and forecasted data for the 7MM during t...

Uterine Leiomyoma (Uterine Fibroids) - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Uterine Leiomyoma (Uterine Fibroids) - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Uterine Leiomyoma (Uterine Fibroids) epidemiology and market outlook for the 7MM. ...

Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 1500 Onwards | By Delve Insight

Introduction DelveInsight's, “Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Relapsing Multiple Scle...

Acute Heart failure (AHF) - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Acute Heart failure (AHF) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Acute Heart failure (AHF) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from ...

Uveal Melanoma - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Uveal Melanoma - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Uveal Melanoma epidemiology and market outlook for the 7MM. Markets Covered - United States...

Renal Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 2000 Onwards | By Delve Insight

Introduction DelveInsight's, “Renal Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Renal Anemia . The report includes informatio...

Acute ischemic stroke (AIS) - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Acute ischemic stroke (AIS) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Acute ischemic stroke (AIS) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period f...

Vancomycin-Resistant Enterococcus Faecium Infections - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Vancomycin-Resistant Enterococcus Faecium Infections - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Vancomycin-Resistant Enterococcus Faecium Infections epidemiology and market ou...

Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 2000 Onwards | By Delve Insight

Introduction DelveInsight's, “Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Restless Legs Syndrome . The report...

Acute Lymphoblastic Leukemia (ALL) - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Acute Lymphoblastic Leukemia (ALL) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Acute Lymphoblastic Leukemia (ALL) epidemiology, providing the historical and forecasted data for the 7MM during the for...

We are on:

Need Help?